↓ Skip to main content

Cochrane Database of Systematic Reviews

Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma

Overview of attention for article published in Cochrane database of systematic reviews, August 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
25 X users
facebook
4 Facebook pages

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
194 Mendeley
Title
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma
Published in
Cochrane database of systematic reviews, August 2015
DOI 10.1002/14651858.cd011397.pub2
Pubmed ID
Authors

Debbie E Anderson, Kayleigh M Kew, Anne C Boyter

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 194 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 <1%
Unknown 193 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 13%
Researcher 20 10%
Student > Bachelor 17 9%
Student > Ph. D. Student 15 8%
Other 13 7%
Other 26 13%
Unknown 77 40%
Readers by discipline Count As %
Medicine and Dentistry 63 32%
Nursing and Health Professions 18 9%
Psychology 10 5%
Social Sciences 6 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Other 8 4%
Unknown 84 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 July 2019.
All research outputs
#1,561,875
of 26,362,953 outputs
Outputs from Cochrane database of systematic reviews
#3,147
of 13,217 outputs
Outputs of similar age
#19,626
of 279,245 outputs
Outputs of similar age from Cochrane database of systematic reviews
#76
of 285 outputs
Altmetric has tracked 26,362,953 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,217 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.6. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,245 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 285 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.